In an attempt to elucidate the mechanism(s) through which the functional adrenal cortex is established, we analyzed immunohistochemically the expression of various markers for the adrenocortical zones, i.e. the zona glomerulosa (zG), the zona fasciculata (zF), and the zona reticularis (zR), as well as markers for the medulla, and further examined the distribution and behavior of DNA-synthesizing cells in rat adrenal glands during development. The results showed that 1) separation of the cortex and medulla, and the development of functional zonation in the cortex began at around the time of birth, 2) at fetal stages when cortical zonation was not established, DNAsynthesizing cells were found scattered throughout the gland, where they proliferated without significant migration, and 3) after birth in the adrenal cortex with established cortical zonation, DNA-synthesizing cells were localized near the undifferentiated zone between zG and zF, and then they migrated centripetally. Cell death appeared to occur in the innermost portion of the cortex, where many resident macrophages are present. These findings illustrate basic processes underlying adrenal development and suggest that the undifferentiated region is apparently the stem cell zone of the adrenal cortex that maintains the cortical zonation. (Endocrinology 140: [3342][3343][3344][3345][3346][3347][3348][3349][3350][3351][3352][3353] 1999) T HE ADRENAL GLAND is composed of two embryologically distinct tissues, the medulla and the cortex. The medullary cells are of neurodermal origin, whereas the cortical ones are of mesodermal origin (1). The adrenal primordium first appears as an isolated clump of rounded cells within the urogenital ridge, and sympatho-adrenal cells then migrate from the neural crest to the primordium (1). In the case of rats, the migration begins around the 15th day of fetal life and continues until term (2, 3). These cells later differentiate into chromaffin cells that form the definite medulla. The cortex is further subdivided into three zones, i.e. the zona glomerulosa (zG), the zona fasciculata (zF), and the zona reticularis (zR); zG cells secrete mineralocorticoids such as aldosterone, and zF cells produce glucocorticoids such as cortisol in primates and corticosterone in rodents. zR cells secrete so-called adrenal androgens in the human and some other animals (1).
T HE ADRENAL GLAND is composed of two embryologically distinct tissues, the medulla and the cortex. The medullary cells are of neurodermal origin, whereas the cortical ones are of mesodermal origin (1) . The adrenal primordium first appears as an isolated clump of rounded cells within the urogenital ridge, and sympatho-adrenal cells then migrate from the neural crest to the primordium (1) . In the case of rats, the migration begins around the 15th day of fetal life and continues until term (2, 3) . These cells later differentiate into chromaffin cells that form the definite medulla. The cortex is further subdivided into three zones, i.e. the zona glomerulosa (zG), the zona fasciculata (zF), and the zona reticularis (zR); zG cells secrete mineralocorticoids such as aldosterone, and zF cells produce glucocorticoids such as cortisol in primates and corticosterone in rodents. zR cells secrete so-called adrenal androgens in the human and some other animals (1) .
We previously demonstrated immunohistochemically that aldosterone synthase cytochrome P450 (P450aldo) and steroid 11␤-hydroxylase (P45011␤) are specifically localized in zG and zF, respectively (4 -6) , defining the biochemical basis for the functional zonation of the rat adrenal cortex. Using these enzymes as markers for the respective cortical zones, we further found a new zone between zG and zF, where cells stained with neither anti-P450aldo nor anti-P45011␤ antibodies; in other words, they did not express both P450aldo and P45011␤ (6) . We also obtained evidence that DNA-synthesizing cells were present in and around this zone, and that cells labeled with 5-bromo-2Ј-deoxyuridine (BrdU) migrated inward from around the new zone in a time-dependent manner. Therefore we have proposed that this zone is an undifferentiated zone and contains stem cells for the adrenal cortex.
Development of the adrenal gland has been studied from histological and biochemical points of view (2, (7) (8) (9) . According to Roos (7) , the adrenal gland on gestational day 18 seems to be histologically mature, with a distinct capsule, a basophilic zG, and palisaded zF and zR. In fact, it was reported that the considerable amount of glucocorticoid was produced at this stage of gestation (10, 11) . However, the amount of aldosterone produced was very low (10) compared with that after birth. Therefore, the discrepancy between the morphological features and the steroidogenic capacity of fetal adrenal glands should be clarified at the molecular level. Employing the adrenocortical zone-specific markers, i.e. P450aldo and P45011␤, together with BrdU and tyrosine hydroxylase for labeling DNA-synthesizing cells and medullary cells, respectively, we investigated the maturation of the adrenal gland, focusing on whether or not the undifferentiated zone described above is involved.
The results indicate that the basic structure of the adrenal gland, i.e. a distinct cortex and medulla, and functional zonation in the cortex including the undifferentiated zone (6) , was almost established at the time of birth. In addition, after birth, DNA-synthesizing cells were found around the undifferentiated zone and then they migrated with time from that area inwards. This contrasts with the distribution seen during the fetal period, where DNA-synthesizing cells were scattered throughout the adrenal gland and then proliferated without significant migration. A preliminary report of this work has appeared elsewhere (12) .
Materials and Methods Animals
Adult female rats of the Sprague-Dawley strain weighing 180 -220 g were placed with males overnight for mating, the day when a vaginal plug was found being considered to be gestational day 0 (G-0). All rats were maintained on a diet of commercial rat pellets and water ad libitum in accordance with the institutional animal care guidelines of the School of Medicine, Keio University. Pregnant rats were killed on gestational days 16 (G-16), 18 (G-18), 19 (G-19) , and 20 (G-20) , and the adrenal glands of fetuses were removed under a dissection microscope. Adrenal glands from rats on postnatal days 1, 2, 7, 10, 25, and 30 (P-1, P-2, P-7, P-10, P-25, and P-30), and adults were also removed. In this study we chose G-16 fetuses as the earliest specimens, because G-16 has been reported to be the stage at which the adrenal gland completes embryogenesis and forms an encapsulated ovoid mass ready for new successive development (2, 7, 8) . After dissection, some adrenal glands were transferred to O.C.T. embedding medium (Miles, Inc., Diagnostics Division, Elkhart, IN) and frozen by immersion in liquid nitrogen to obtain fresh-frozen sections. Some glands were placed in 70% ethanol or 4% paraformaldehyde in 10 mm PBS, pH 7.0, (PBS) overnight at 4 C to obtain paraffin sections.
Immunohistochemical studies
Immunohistochemical localization of steroidogenic enzymes was performed on 6-m sections of a fresh-frozen adrenal gland as previously described (5, 6) . The antibodies used were raised, in rabbits, against rat P450aldo (5), rat P45011␤ (5), and bovine P450scc (cholesterol side-chain cleavage enzyme) (13) . Since an oligopeptide used to raise antibody against P45011␤ (5) was the same as the corresponding amino acid sequence of P450c11B3 (14) , the antibody used to identify P45011␤ in this study probably cross-reacted with P450c11B3 as well. Antiguinea pig P450c21 (steroid 21-hydroxylase) antibody (15) and antibovine Ad4-binding protein (Ad4BP) antibody (16) were generous gifts from Drs. S. Takemori and S. Kominami of Hiroshima University (Hiroshima), and Dr. K. Morohashi of the National Institute for Basic Biology (Okazaki), respectively. Commercially available antibodies for rat tyrosine hydroxylase, bovine phenylethanolamine-N-methyl transferase, Fos family protein (17) , and rat resident macrophages (18) were products of Sigma Chemical Co. (St. Louis, MO), PROTOS Biotech Co. (New York, NY), Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and BMA Biochemicals Ltd. (Augst, Switzerland), respectively. Double staining, i.e. staining with two different antigens of a single specimen, was carried out by essentially the same method as that of Nakane (6, 19) .
To detect DNA-synthesizing cells, pregnant rats were injected ip with 50 mg 5-bromo-2Ј-deoxyuridine (BrdU) (Sigma Chemical Co.)/kg body wt 1 h before they were killed (20, 21) , and then the fetuses were collected from the uterine horns. BrdU was also injected ip into postnatal rats 1 h before killed. Immunohistochemical staining with BrdU of fresh-frozen or paraffin adrenal sections was performed using a mouse monoclonal anti-BrdU antibody (Becton Dickinson and Co., Mountain View, CA) as described previously (22) . Immunohistochemical localization of proliferating cell nuclear antigen (PCNA) (23) was performed on alcohol-fixed paraffin sections (4-m) of the adrenal gland using the monoclonal antibody PC-10 (DAKO Japan Co., Ltd., Kyoto Japan) (24, 25) .
Enzymatic histochemical localization of alkaline phosphatase and dipeptidyl aminopeptidase IV
To visualize capillary networks of the adrenal gland, fresh frozenadrenal sections (6-m) were stained histochemically for the activities of alkaline phosphatase (ALP) and dipeptidyl aminopeptidase IV (DAP IV) (26, 27) according to the method of Batra et al. (27) . Double staining with ALP and DAP IV of the same section has been used to demonstrate the capillary bed in many organs (26) ; the reaction for ALP reveals the arterial part of capillaries, whereas DAP IV activity reveals the endothelium in the venous part of the capillary bed. The function of DAP IV in the endothelium, however, has not been clarified, and it is only suggested that DAP IV takes a part in the degradation of some vasoactive peptides (26) .
In situ hybridization analysis
In situ hybridization analyses were performed on fresh-frozen adrenal sections with digoxigenin (DIG)-labeled cRNA probes (28) (34) were cloned into pGEM-4Z (Promega Biotech, Madison, WI). DIG-labeled sense and antisense RNA probes were prepared with T7 and SP6 RNA polymerase, respectively, in the presence of DIG-labeled UTP (Roche Molecular Biochemicals, Mannheim, Germany). RNA probes were then partially degraded to an average size of 100 -150 nucleotides by alkaline hydrolysis. Rat AT 1B receptor cDNA was a generous gift from Dr. K. Sandberg of NIH (Bethesda, MD).
Fresh-frozen sections on 3-aminopropyltriethoxysilane (APS)-coated glass slides were stood at room temperature and then at 37 C for 30 min each. The slides were then incubated at room temperature sequentially in 4% PFA/PBS for 40 min, acetone for 5 min, and 0.1% Triton X-100/PBS for 5 min. In between the treatments, the slides were washed with PBS. They were then successively treated at room temperature with proteinase K (10 g/ml) (Sigma Chemical Co.) for 30 min (for adult adrenal glands) or 15 min (for fetal and early postnatal adrenal glands), 4% PFA/PBS for 5 min, and 0.2% glycine/PBS for 10 min. The slides were immersed in a prehybridization medium comprising 2 ϫ SSC (1 ϫ SSC: 0.15 m NaCl and 0.015 m trisodium citrate) and 50% formamide for 1 h at 45 C. DIG-labeled RNA probes were diluted to 0.5 g/ml with a hybridization medium (20 mm Tris/HCl, pH 8.0, containing 2.5 mm EDTA, 0.3 m NaCl, 50ϫ Denhardt's solution [Sigma Chemical Co., 0.02% Ficol/0.02% BSA/0.02% polyvinylpyrolidine], 10% dextran sulfate, 1 mg/ml yeast transfer RNA[Sigma Chemical Co.], and 50% deionized formamide). The hybridization was carried out under a coverslide in a moist chamber at 45 C. After about 16 h, the coverslides were gently removed and the glass slides were washed in 2 ϫ SSC containing 50% formamide for 60 min at 45 C, followed by a brief wash with 10 mm Tris/HCl-0.5 m NaCl, pH 8.0, for 5 min twice. They were then treated with ribonuclease A (Sigma Chemical Co.; 20 g/ml in 10 mm Tris/ HCl-0.5 m NaCl, pH 8.0) for 30 min at 37 C, and washed with 2 ϫ SSC containing 50% formamide at 45 C for 1 h twice and at room temperature for 1 h once. The slides were next washed in buffer 1 (100 mm Tris/HCl, pH 7.5, containing 150 mm NaCl), and then incubated with 0.5% blocking reagent (Roche Molecular Biochemicals) in buffer 1 at room temperature for 30 min. After a brief wash in buffer 1, the slides were treated with 5% normal sheep serum in buffer 1 for 30 min. The slides were then incubated at room temperature for 1 h with ALP-conjugated sheep anti-DIG antibody (Roche Molecular Biochemicals) in buffer I containing 5% normal sheep serum. The unbound antibodies were removed by washing with buffer 1 three times for 10 min each. The slides were then equilibrated with buffer 2 (0.1M Tris/HCl, pH 9.5, containing 0.1 m NaCl and 0.05 m MgCl 2 ), and incubated with an ALP substrate solution (0.4 mm 4-nitrobluetetrazolium chloride, 0.42 mm 5-bromo-4-chrolo-3-indolyl phosphate [Roche Molecular Biochemicals], and 0.27 mg levamisole/ml in buffer 2). The color reaction (dark purple-blue) was stopped by immersing the slides for 10 min in buffer 3 (10 mm Tris/HCl, pH 8.0, containing 1 mm EDTA). For control experiments to confirm the specificity of hybridization signals, DIG-labeled sense cRNA probes were used at the same concentrations as the corresponding antisense probes. However, no specific signal was observed.
Detection of fragmented DNA
Fragmented DNA in adrenal glands was detected in situ by the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) method of Gavrieli et al. (35) . Adrenal glands were fixed overnight at 4 C in 4% paraformaldehyde/PBS and then embedded in paraffin. Four-micrometer-thick sections were deparaffinized by heating at 50 C for 30 min and then washing three times in xylol for a total of 10 min.
The rehydrated adrenal sections were subjected to in situ end labeling of fragmented DNA according to the instructions for an In situ Cell Death Detection Kit (Roche Molecular Biochemicals). A section as a positive control was incubated with DNase I (Roche Molecular Biochemicals) at 10 U/l in 0.1 m Na-acetate, pH 5.5, containing 1 mm CaCl 2 and 5 mm MgCl 2 for 10 min at room temperature before incubation with the mixture comprising terminal deoxynucleotidyl transferase and biotinylated dUTP in the In situ Cell Death Detection Kit of Roche Molecular Biochemicals. All nuclei in the glands were stained, showing that they were completely fragmented.
Immunoblot analysis
Homogenates of adrenal glands from pre-and postnatal rats were subjected to SDS-PAGE (7.5% polyacrylamide gel) (36) , and then blotted onto polyvinylidene difluoride membranes (4). Enhanced chemiluminescence Western blot reagents (Amersham Pharmacia Biotech, Buckinghamshire, UK) were employed for identification of P45011␤ after incubation of the membranes with anti-P45011␤ antibody. The intensity of signals accumulated on a phosphor screen was measured after 30 min exposure at room temperature with a Molecular Imager GS-525 (Nippon Bio-Rad Co., Tokyo, Japan) within the range of linear responses. Figure 1 shows the localization of P450aldo, P45011␤, and tyrosine-hydroxylase (TH) together with that of the microvasculature in rat adrenal glands during late gestational development. At G-16, P450aldo-positive cells were undetectable in the adrenal gland ( Fig ( Fig. 1 , G-16:P45011␤), although the intensity of the staining was somewhat faint in the outermost portion of the gland. Thus, the bulk of cortical cells appeared to have the properties of zF cells. Cells that did not stain with the anti-P45011␤ antibody were observed inside the gland, most of which turned out to stain positive for tyrosine hydroxylase (TH) (Fig. 1, G-16 :TH), which is a rate-limiting enzyme in catecholamine biosynthesis and is known as a sensitive index of sympatho-adrenal precursors (1, 37) . The TH-positive cells did not concentrate in the center of the gland as seen in the adult medulla, but were scattered, indicating that a medullary structure had not been formed at this stage of gestation. Almost no ALP and DAP IV activities were detected in a G-16 fetal adrenal gland (Fig. 1 , G-16:ALP & DAP IV). Thus, the microvasculature of the adrenal gland at G-16 was immature.
Results

Expression of P450aldo, P45011␤, tyrosine-hydroxylase, and formation of the microvasculature in rat adrenal glands during the late gestational period
At G-19, P450aldo-positive cells were still difficult to detect (Fig. 1 , G-19:P450aldo), although a narrow layer consisting of relatively small and tightly-packed cells corresponding to zG cells was observed in the outermost portion of the gland. Within the gland, most of the cells that did not stain for P45011␤ were TH-positive ones as in the adrenal gland of a G-16 fetus (Fig. 1 , G-19:TH). Some of the THpositive cells also stained with antibody against phenylethanolamine-N-methyl transferase, an epinephrine-synthesizing enzyme specifically present in the medulla (38) (data not shown). At this time, capillaries became histochemically detectable in the adrenal gland (Fig. 1 
, G-19:ALP & DAP IV).
At G-20, P450aldo-positive cells were now seen in some areas of the outermost portion of the cortex ( 
Expression of P450aldo, P45011␤, tyrosine hydroxylase, and formation of the microvasculature in rat adrenal glands during the early postnatal period
The localization of P450aldo, P45011␤ and tyrosine hydroxylase (TH) together with that of the microvasculature in adrenal glands during the early postnatal period is shown in Fig. 2 . One day after birth (P-1), a P450aldo-positive layer was clearly recognized in the outer part of the gland, showing that the number of functionally active zG cells had increased ( Fig. 2 , P-1:P450aldo). The intensity of P450aldo staining increased afterwards with time examined up to P-25 (P-25: P450aldo). At later stages, however, the intensity decreased (Fig. 2 , adult:P450aldo). Figure 2 also shows the double staining of adrenal sections with anti-P450aldo and anti-P45011␤ antibodies. On postnatal day 1, a narrow P450aldo-positive cell layer was present just beneath the capsule, as described above, and then a wide P45011␤-positive cell layer was observed ( Fig. 2 , P-1:P450aldo & P45011␤). Furthermore, in between, a cell layer without P450aldo and P45011␤ (6) was clearly recognized for the first time, and this zone was thereafter constantly observed in the gland (Fig. 2 , P-25 and adult:P450aldo & P45011␤). Meanwhile, TH-positive cells were still intermingled with P45011␤-positive cells at P-1, although they were rather gathered in the center of the gland (Fig. 2 , P-1: TH). By the third day of life, TH-positive cells, which were increasing in number, were coalesced into a well-defined medulla (data not shown) like in adrenal glands at P-25 ( Fig.  2 , P-25:TH) and in adult rats (Fig. 2, adult:TH) .
In the adrenal gland at P-25, a cortical area near the medulla still strongly stained with anti-P45011␤ antibody (Fig.  2 , P-25:P450aldo & P45011␤). Because such intensity of P45011␤ staining was stronger than that in zR of adult adrenal glands (Fig. 2 , adult:P450aldo & P45011␤, and refer to Ref. 6) , it is likely that zR cells had not appeared yet in P-25 rats. The observation that anastomosing sinusoidal capillaries, which is one of typical features of zR, were not apparent at the innermost edge of the cortex (P-25:ALP & DAP IV) may also support this statement. zR cells at P-25, if any, might be very immature and low in number. Within the following several days, zR became clearly discernible morphologically in the innermost part of the cortex (data not shown), showing the establishment of the cortical zonation.
As described in Materials and Methods, the antibody raised against rat P45011␤ and used in this study probably crossreacted with P450c11B3 (14) . The expression of P450c11B3 mRNA has been demonstrated in the zFR of rat adrenal cortex from several days to 1 month after birth (14) . Therefore, immunohistochemical staining of early postnatal adrenal sections with the anti-P45011␤ antibody may reveal also the presence of P450c11B3. However, no further examination was performed to discriminate between P45011␤ and P450c11B3, because P450c11B3 has capacity of 11␤-and 18-hydroxylation of deoxycorticosterone, but no ability to produce aldosterone.
Localization of mRNAs for P450aldo, P45011␤, and P450scc in adrenal glands during the late gestational and early postnatal stages
The developmental expression of zone-specific enzymes described above was further examined at the mRNA level by in situ hybridization together with that of P450scc, which is the rate-limiting enzyme functioning at the early common step in adrenocortical steroidogenesis. As shown in Fig. 3 , P450aldo mRNA was undetectable at G-18 (G-18:P450aldo mRNA) as the P450aldo protein was not observed until G-20 (refer to the results in Fig. 2) , whereas P45011␤ and P450scc mRNAs were detected already throughout the adrenal gland at G-16, except for in TH-positive cells and the outermost region of the gland. In the outermost region, signals of P45011␤ mRNA and P450scc mRNA were almost absent and weak, respectively (G-18:P45011␤ mRNA, P450scc mRNA).
Around the time of birth, P450aldo mRNA-expressing cells were clearly present in the outermost portion of the gland (P-1:P450aldo mRNA). A P45011␤ mRNA-expressing zone was seen inside of the P450aldo mRNA-expressing zone (compare P-1:P45011␤ mRNA with P-1:P450aldo mRNA in Fig. 3 ), whereas P450scc mRNA was expressed in P450aldo mRNA-expressing zG cells and P45011␤ mRNA-expressing zF cells, and also cells in the undifferentiated zone at different intensities (P-1:P450scc mRNA).
The signal intensity of P45011␤ mRNA like that of P450scc mRNA right after birth ( Fig. 3, P-1) , however, was weaker than those before birth (Fig. 3, G-18 ). In the adrenal gland at P-25, the signals were intensified again ( Fig. 3, P-25 ). According to the results of immunoblot analyses shown in Fig.  4 , the amounts of the P45011␤ protein in homogenates of rat adrenal glands at G-18, G-20, P-1 and P-10 were not significantly different from each other. The analytical immunoblot data thus agreed well with the immunohistochemical results (refer to Figs. 1 and 2 ), which showed almost no difference in the intensity of P45011␤ staining in adrenal glands at G-20 and P-1. The significance of the decrease in the P45011␤ mRNA level right after birth will be discussed in the following section.
Expression of a Fos-family protein in adrenal glands during development
In our previous studies, P45011␤ gene (CYP11B1) transcription was found to be activated by transcription factor AP-1 (39, 40) . We therefore analyzed the distribution of the Fos-family protein, which comprised the AP-1 factor, in the adrenal gland during development (Fig. 5) .
In adrenal glands at G-18 and G-20, Fos-family proteinpositive staining was seen in the nuclei of most cortical cells (Fig. 5, G-18, G-20) , which also stained with the antibody against P45011␤. From P-1 ( Fig. 5, P-1 ) through 1 week after birth, however, the staining intensity of the Fos-family pro-
FIG. 2. Localization of P450aldo, P45011␤, tyrosine hydroxylase (TH)
, and capillaries in rat adrenal glands during early postnatal development. Fresh-frozen sections of rat adrenal glands at P-1 and P-25, and adult rat adrenal glands were subjected to single staining with anti-P450aldo (dark blue), double staining with anti-P450aldo (dark blue in the case of a P-1 section, and brown in the case of P-25 and adult sections) and anti-P45011␤ (brown), and single staining with anti-TH (grayish blue) antibodies. In double stained sections, P450aldo and P45011␤ are localized in zG and zF, respectively. Note that the light blue area in the outer portion of TH-stained sections is not significant. Capillaries were recognized as described in Fig. 1 . Nuclei (light blue dots) in TH-stained sections were poststained with methyl green. (magnification: ϫ70 for P-1 and P-25 adrenal glands; ϫ35 for adult adrenal gland) tein was weak. Such a phenomenon correlated well with the weak signal of P45011␤ mRNA during the neonatal period as described above (Fig. 3 , P-1:P45011␤ mRNA), although it remains to be determined why the the down-regulation of the P45011␤ mRNA level did not lead to a decrease in the amount of the P45011␤ protein (refer to Fig. 4) . The strong intensity of the Fos-family protein staining was seen again in the nuclei of cortical cells around 2 weeks after birth ( Fig. 5, P-16 ). Nuclei in zG cells did not stain with the anti-Fos-family protein antibody (see zG at P-16 and in adults in Fig. 5 ).
Expression of angiotensin receptor mRNA in adrenal glands during development
We have previously shown that the expression of P450aldo is stimulated by angiotensin II (41, 42) , which acts via the angiotensin receptor (AT). Therefore, whether or not the expression of P450aldo during adrenal development is related with expression of the angiotensin receptor was investigated by in situ hybridization. Among the angiotensin receptor subtypes so far reported, AT 1B receptor was chosen for this purpose because it is known to be expressed predominantly in zG of the adult adrenal cortex and is thought to be involved mainly in water and salt homeostasis (34) . As shown in Fig. 6 , the adrenal gland at G-16 already showed a signal of AT 1B receptor mRNA in its outer part (Fig. 6,  G-16 ). The signal was always detected afterwards in morphologically recognized-zG cells. The signal was undetectable in zFR and the medulla.
The results suggest that, although AT 1B receptor mRNA is already present in adrenal glands at G-16, AT 1B receptor is not functionally mature yet or the concentration of angiotensin II in plasma is not sufficient, resulting in no expression of P450aldo until G-20 (refer to Fig. 1 and Discussion) . Fresh-frozen adrenal sections from rats at G-18, P-1, and P-25, and adult rats were subjected to in situ hybridization using DIG-labeled RNA probes for P450aldo, P45011␤ and P450scc. Note that the significant signal of P450aldo mRNA is only observed in the outermost portion of the adrenal gland at P-1 and P-25, and in adulthood (magnification, ϫ56). 
Proliferating cells in adrenal glands during late gestational and early postnatal development
To study the relationship between the differentiation of the adrenal gland so far observed and replicating cells in the gland, the localization of DNA-synthesizing cells and their behavior were investigated during development.
In fetal adrenal glands at G-16 and G-18, cells containing BrdU-labeled nuclei (BrdU-labeled cells), i.e. 19 Ϯ 2% of total adrenal cells, were found scattered throughout the gland (Fig. 7, G-16 and G-18:BrdU). From G-19 to the neonatal period, BrdU-labeled cells, i.e. 6 Ϯ 2% of total adrenal cells, were found in two regions, one was the outermost portion and the other was around the central region of the gland (Fig.  7 , P-1:BrdU). One week after birth, these cells, i.e. 4 Ϯ 1% of total adrenal cells, were found in a subcapsular portion including the undifferentiated zone (6) (Fig. 7 , P-7:BrdU). Thirty days after birth, most BrdU-labeled cells, i.e. 0.9 Ϯ 0.2% of total adrenal cells, were found around the undifferentiated zone and the uppermost portion of zF ( Fig. 7 , P-30: BrdU), with some at the border between the cortex and medulla like in adult adrenal glands (6) . Figure 7 also includes the localization of proliferating cell nuclear antigen (PCNA), which is one of the endogenous markers for the replicating cells (23) . As shown in Fig. 7 :PCNA, the localization of PCNA-containing cells in fetal and early postnatal adrenal glands was almost the same as that of BrdU-labeled cells, but their numbers were greater than those of BrdUlabeled cells. This may be due to the fact that BrdU is incorporated into the nuclei of cells in the S-phase (20, 21) , whereas PCNA is present in the nuclei of cells in both the Sand late G1-phases (23) .
Pulse-chase study of BrdU-labeled proliferating cells
Pulse-chase experiments with BrdU were performed to investigate the cellular mechanisms underlying the growth and maintenance of adrenocortical cells during development (Fig. 8) . Three developmental stages were chosen as times for BrdU-administration: G-16, the stage at which the adrenal gland first appeared as an encapsulated ovoid mass; G-18, the stage just before establishment of the cortical zonation; and P-10, the stage of establishment of the cortical zonation and the medullary structure.
When BrdU was injected at G-16, BrdU-incorporating cells were found to be distributed uniformly in the gland (Fig. 8,  A-1) , as shown already in Fig. 7. Two days later, i. e. at G-18, cells labeled with BrdU at G-16 were still observed scattered over the gland (Fig. 8, A-2 ), although their number had -frozen adrenal sections from rats at G-16, G-18 , G-20, P-3, and P-25, and from adult rats were subjected to in situ hybridization using a DIG-labeled RNA probe for AT 1B receptor mRNA. The black dots in the outermost portion of the adrenal gland represent the signal of AT 1B receptor mRNA. Note that the outer edge of the signal portion in a G-16 adrenal section corresponds to the edge of the adrenal gland (magnification, ϫ56).
increased to almost twice as many as that at G-16. Similarly, cells incorporating BrdU at G-18 were found throughout the whole adrenal gland as described (Fig. 7) , and 2 days later (i.e. G-20) about twice as many positive cells as at G-18 were still present uniformly in the gland (data not shown). Ten days (i.e. P-7) to 16 days (i.e. P-13) after injection, BrdU-labeled cells were found to have moved with time closer to the medulla except for some BrdU-labeled cells in the outermost region of the gland. On the 23rd day (i.e. P-20) after injection, only several BrdU-positive cells with very weak intensity were detectable in the innermost portion of the cortex. These results show that cells labeled with BrdU at G-18 proliferated without movement in one direction during the fetal period, but after birth they migrated centripetally and finally underwent degeneration at the border between the innermost edge of the cortex and the medulla. When BrdU was injected again into P-20 rats, which had received the first BrdU injection at G-18, BrdU was incorporated into the nuclei of cells around the undifferentiated zone, indicating again that cells in and around the undifferentiated zone have replicating ability, and function as stem cells for the adrenal cortex.
The results of the pulse-chase study after injection of BrdU into rats at P-10 are shown in Fig. 8-B . BrdU-labeled cortical cells were present abundantly in the outer portion, including the undifferentiated zone, (Fig. 8, B-1 ) and then migrated toward the inside of the gland with time (2 days after injection: Fig. 8-B-2 , and 7 days after injection: Fig. 8-B-3) , leaving some BrdU-labeled cells in the peripheral region of the gland behind. Furthermore, the numbers of BrdU-labeled cells in both the cortex and medulla increased about twice in the first 2 days (Fig. 8, B-2 ) and furthermore about 3-fold in 7 days (Fig. 8, B-3) . In early postnatal stages as well as in adulthood (6), the migration of proliferating cortical cells from the undifferentiated zone may be important for the growth and differentiation of the adrenal cortex.
Sites for physiological cell death in the adrenal gland during development
It has been considered that the development of the adrenal gland together with cortical zonation requires a dynamic balance among growth, functional differentiation and physiological cell death, like in many other tissues (43) (44) (45) (46) . Therefore, the sites for physiological cell death, which is called apoptosis or programmed cell death (44, 47) , were investigated in the adrenal gland by detecting fragmented-DNA in nuclei. The nuclear DNA-fragmentation has been reported to be one of the reliable diagnostic criteria for the occurrence of apoptosis (35) . During the late gestational and neonatal stages, signals of fragmented-DNA were found scattered throughout the adrenal gland (as a typical example: Fig. 9 , G-20 fragmented-DNA), but after birth they gradually became confined to the border between the innermost edge of the cortex and the medulla (as a typical example: Fig. 9 , P-10 fragmented-DNA, and also refer to Ref. 48) .
Recently, several reports on the distribution and characterization of macrophages in adult adrenal glands were published (49 -51) . Because apoptotic cells are known to be phagocytosed by macrophages (43, 52) , the relationship between the localization of macrophages and that of degenerating cells with DNA-fragmented nuclei was investigated. The antibody used to detect macrophages was a monoclonal antibody, Ki-M2R (18), which was raised against normal rat peritoneal macrophages and able to discriminate resident macrophages from peripheral blood monocytes and immune accessories (53) . The data showed that Ki-M2R-positive cells were scattered throughout the adrenal gland in the fetal period (Fig. 9 , G-20 resident macrophage), while around the time when the cortical zonation was established, they were found abundantly in the center of the gland, i.e. the innermost portion of the cortex and the medulla (Fig. 9 , P-10 resident macrophage). Thus Ki-M2R-positive cells were present around the area where cells with fragmented DNA-containing nuclei existed (Fig. 9, fragmented DNA) . Ki-M2R-positive cells seem to be involved in the disposal of dying cells in the adrenal gland.
These phenomena, taken together, imply a mechanism for cell renewal in the adrenal cortex where zonation is established and macrophages is localized in the center of the cortex; cortical cells present in and around the undifferentiated zone (6) have replicating ability, migrate centripetally, and finally undergo degeneration within resident macrophages present in the innermost part of the cortex.
Discussion
We investigated in detail the course of functional maturation of the adrenal glands of rats from G-16 to P-30 using functional markers for the cortical zones and the medulla as well as the localization and behavior of DNA-synthesizing cells in these adrenal glands.
Although P45011␤ (Fig. 1 , G-16:P45011␤) as well as P450scc and P450c21 (data not shown) were expressed already in adrenal glands at G-16, P450aldo was detected for the first time in the outermost portion of the adrenal gland at around G-20, just 1 day before birth (Fig. 1, G-20:P450aldo) , showing the appearance of functionally active zG cells. In fact, the amount of aldosterone in the fetal adrenal gland has been reported to increase from around G-20, with a peak at around the time of birth (10) . In addition, renin (54), angiotensin converting enzyme (55) , and angiotensinogen (56) , which are necessary to produce angiotensin II, have been found to increase at around the time of birth. The appearance of P450aldo at around G-20 observed in this study (Fig. 1 ) is well coincident with these events. These reported phenomena may further explain why there is no expression of P450aldo until G-20 even if AT 1B receptor mRNA is already expressed in G-16 fetal adrenal glands (Fig. 6) .
In addition, the onset of expression of P450aldo may also be related to the concentration of ACTH in the plasma of fetuses. According to the results of our recent studies involving adult rats, suppression or stimulation of ACTH secretion resulted in an increase or a decrease in the number of P450aldo-positive cells in zG, respectively (57) . The ACTH concentration in rat fetal plasma has been reported to increase until G-19 and to decrease thereafter (58) . Therefore, the low concentration of ACTH in plasma after G-19 (10, 11) may result in the expression of P450aldo. In any event, our results demonstrate that functional zonation of the adrenal cortex, including the undifferentiated zone (6) , is established around the time of birth. According to the results of Naka- hara et al., a lipid free-transitional zone (59) , which resembles the undifferentiated zone (6), was morphologically recognizable at around the time of birth (9) .
The cytokinetics of adrenocortical cells have been studied to investigate the mechanism(s) underlying the process of the cortical zonation by using [ 3 H]-thymidine or BrdU as a marker for replicating cells (22, 60 -63) . Most studies have shown that adrenocortical cells present in the subcapsular portion of the gland have replicating ability, and those cells migrate centripetally from that area toward the center, suggesting that stem cells of the cortex are present in the outermost portion and differentiate to zF cells and zR cells during migration. These results support one of currently prevailing hypotheses for adrenocortical cytogenesis, i.e. migration theory, originally expressed by Gottschau (64) . The existence of stem cells in adult adrenal glands has been inferred also from observations, such as regeneration of the adrenal cortex after enucleation (22, 65, 66) or the growth and differentiation of some adrenocortical cells in cultures under certain conditions (67, 68) . On the other hand, we have recently proposed that stem cells of the adrenal cortex of adult rats exist in and around the undifferentiated zone between zG and zT, based on the functional and morphological observations (6) . Compared with numerous reports on the cell renewal system in the adult adrenal gland, those concerning the cytogenic system in the fetal adenal gland are very few. The earliest adrenal glands so far examined were from rats at G-20, i.e. 1 day before birth, where cortical cells in the outer portion of the gland predominantly incorporate [ 3 H]-thymidine and then they migrate centripetally (61) like in the adult adrenal gland. According to our present results, in the adrenal gland at G-20 the cortical zonation begins, and most DNA-synthesizing cells are present in the outer portion of the gland as in the adult adrenal gland. In this study, the adrenal glands of fetuses at earlier stages than G-20, i.e. G-16 and G-18, were employed for the first time to investigate the localization and behavior of DNA-synthesizing cells in fetal glands. Adrenal glands at these stages of gestation were immature both structurally and functionally, i.e. the cortical cells and the medullary cells were intermingled with each other, and the cortical zonation was not yet recognizable (Fig.  1) . In such adrenal glands, DNA-synthesizing cells were found scattered throughout the adrenal gland (Fig. 7) . In addition, they proliferated rapidly without significant migration (Fig. 8) . These results are consistent with the view of Morley et al. (69) in that the centripetal migration of replicating cells observed in the adult adrenal cortex is not a major mechanism for growth of the fetal adrenal cortex. They observed a variegated and radial pattern of ␤-galactosidase reporter staining in the adrenal cortex of adult transgenic mice carrying a steroid 21-hydroxylase promoter/␤-galactosidase reporter gene, but a variegated island pattern of ␤-galactosidase reporter staining in the glands of fetal transgenic mice (69) . Taken together, these results suggest that there exists a distinct cellular mechanism(s) contributing to adrenal development at gestational stage, which is different from that in mature adrenal glands.
Finally, whether or not cortical cells of the undifferentiated zone, i.e. stem cells of cortical cells, observed in adult adrenal gland (6) exist in fetal adrenal glands should be mentioned. As described, in fetal adrenal glands before G-20, cortical zonation and even separation between the cortex and medulla are not observed, and there exist abundant DNA-synthesizing cells throughout. Therefore, in preliminary experiments, anti-Ad4BP/SF-1 (70, 71) antibody was employed to label all cortical cells in fetal adrenal glands. Ad4BP/SF-1 has been reported to be a steroidogenic tissue-specific nuclear receptor (70, 71) , and in the adrenal gland it is expressed in the nuclei of cortical cells including cells of the undifferentiated zone (16) . As shown in Fig. 10 (A and the magnified view in B), most cells with Ad4BP-positive nuclei (black dots) in G-16 fetal adrenal glands were found to be P45011␤-positive (gray color), but some Ad4BP-positive cells in the outermost portion seemed not to stain with the anti-P45011␤ FIG. 9 . Localization of cells with fragmented DNA-containing nuclei and resident macrophages in adrenal glands during development. Cells with fragmented DNA-containing nuclei appear as black dots in paraffin sections at G-20 and P-10 (fragmented DNA). Resident macrophages appear black in the fresh-frozen sections (resident macrophage). Nuclei (gray dots) were poststained with methyl green. zG, zF, and M denote the zona glomerulosa, the zona fasciculata, and the medulla, respectively. (magnification, ϫ100) antibody, showing they might be undifferentiated cells. The faint or almost no signal of P45011␤ mRNA in the outermost portion of the G-18 fetal gland (Fig. 3 ) may also support this possibility. Another possibility that such undifferentiated cells exist in a small number inside the fetal adrenal gland cannot be ruled out. It seems, however, technically difficult to detect such undifferentiated cortical cells in fetal adrenal glands, because no specific markers are known for these cells. It is thus obviously important to identify specific markers to detect undifferentiated cells in the adrenal cortex, and such factors are now under investigation in our laboratory.
